Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,708 public trials 1,048 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia

NCT03195491

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

Local Institution Beijing, Beijing Municipality, China

View all 30 locations

View Trial Details

Completed

A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) Inhibitors

NCT03546894

Conditions: Anaplastic Lymphoma Kinase-positive, Bronchial Neoplasms, Carcinoma Non-small-cell Lung, +9 more
Locations: EmpiraMed, Inc. Maynard, Massachusetts, United States

View Trial Details

Completed

A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence

NCT03560791

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: St. Elizabeth Healthcare Edgewood, Kentucky, United States

View Trial Details

Completed

Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

NCT04207775

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Beijing, China

Research Site Changsha, China

Research Site Chengdu, China

Research Site Chengdu, China

View all 16 locations

View Trial Details

Completed

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

NCT03091816

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery

NCT00254384

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions: Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations: UC San Diego Moores Cancer Center San Diego, California, United States

University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

View all 18 locations

View Trial Details

Completed

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

NCT03502330

Conditions: Adenocarcinoma, Advanced Melanoma, Bronchial Neoplasms, +24 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

View Trial Details

Completed

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

NCT04480372

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +16 more
Locations: HFR Fribourg Fribourg, Villars-sur-Glâne, Switzerland

Kantonsspital Aarau Aarau, Switzerland

Kantonsspital Baden Baden, Switzerland

Universitaetsspital Basel Basel, Switzerland

View Trial Details

Completed

Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone

NCT01513174

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: H. Germans Trias i Pujol Badalona, Barcelona, Spain

ICO Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain

H. Teresa Herrera A Coruña, Spain

H. Gen. Universitario de Alicante Alicante, Spain

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions